132 related articles for article (PubMed ID: 23707658)
1. Axl and prostasin are biomarkers for prognosis of ovarian adenocarcinoma.
Chen PX; Li QY; Yang Z
Ann Diagn Pathol; 2013 Oct; 17(5):425-9. PubMed ID: 23707658
[TBL] [Abstract][Full Text] [Related]
2. Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression.
Chen PX; Li QY; Yang Z
Pathol Oncol Res; 2015 Sep; 21(4):1133-40. PubMed ID: 25971681
[TBL] [Abstract][Full Text] [Related]
3. Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression.
Sato K; Suda K; Shimizu S; Sakai K; Mizuuchi H; Tomizawa K; Takemoto T; Nishio K; Mitsudomi T
PLoS One; 2016; 11(4):e0154186. PubMed ID: 27100677
[TBL] [Abstract][Full Text] [Related]
4. Computational and Immunohistochemical Analyses Highlight AXL as a Potential Prognostic Marker for Ovarian Cancer Patients.
Lozneanu L; Pinciroli P; Ciobanu DA; Carcangiu ML; Canevari S; Tomassetti A; Căruntu ID
Anticancer Res; 2016 Aug; 36(8):4155-63. PubMed ID: 27466525
[TBL] [Abstract][Full Text] [Related]
5. AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer.
Dunne PD; McArt DG; Blayney JK; Kalimutho M; Greer S; Wang T; Srivastava S; Ong CW; Arthur K; Loughrey M; Redmond K; Longley DB; Salto-Tellez M; Johnston PG; Van Schaeybroeck S
Clin Cancer Res; 2014 Jan; 20(1):164-75. PubMed ID: 24170546
[TBL] [Abstract][Full Text] [Related]
6. Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer.
Di Benedetto A; Mottolese M; Sperati F; Ercolani C; Di Lauro L; Pizzuti L; Vici P; Terrenato I; Shaaban AM; Humphries MP; Sundara-Rajan S; Barba M; Speirs V; De Maria R; Maugeri-Saccà M
J Cell Physiol; 2017 Aug; 232(8):2246-2252. PubMed ID: 27987320
[TBL] [Abstract][Full Text] [Related]
7. Axl is a prognostic marker in oral squamous cell carcinoma.
Lee CH; Yen CY; Liu SY; Chen CK; Chiang CF; Shiah SG; Chen PH; Shieh YS
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S500-8. PubMed ID: 21842265
[TBL] [Abstract][Full Text] [Related]
8. Higher expression of receptor tyrosine kinase Axl, and differential expression of its ligand, Gas6, predict poor survival in lung adenocarcinoma patients.
Ishikawa M; Sonobe M; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Date H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3(Suppl 3):S467-76. PubMed ID: 23242819
[TBL] [Abstract][Full Text] [Related]
9. Axl Is a Potential Cancer Prognostic Marker for the Migration and Invasion of Nasopharyngeal Carcinoma.
Jiang C; Zhou L; Wang H; Zhang Q; Xu Y
Adv Clin Exp Med; 2016; 25(3):531-7. PubMed ID: 27629742
[TBL] [Abstract][Full Text] [Related]
10. YES-associated protein 1 promotes adenocarcinoma growth and metastasis through activation of the receptor tyrosine kinase Axl.
Cui ZL; Han FF; Peng XH; Chen X; Luan CY; Han RC; Xu WG; Guo XJ
Int J Immunopathol Pharmacol; 2012; 25(4):989-1001. PubMed ID: 23298489
[TBL] [Abstract][Full Text] [Related]
11. Association of pancreatic adenocarcinoma up-regulated factor expression in ovarian mucinous adenocarcinoma with poor prognosis.
Kim SK; Song SY; Kim S; Cho NH; Yim GW; Kim SW; Kim YT; Nam EJ
Int J Clin Exp Pathol; 2014; 7(8):5103-10. PubMed ID: 25197383
[TBL] [Abstract][Full Text] [Related]
12. PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance.
Tian X; Yan L; Zhang D; Guan X; Dong B; Zhao M; Hao C
Oncol Rep; 2016 Oct; 36(4):1829-36. PubMed ID: 27499181
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of receptor tyrosine kinase AXL and EGFR in human primary lung adenocarcinomas.
Wu Z; Bai F; Fan L; Pang W; Han R; Wang J; Liu Y; Yan X; Duan H; Xing L
Hum Pathol; 2015 Dec; 46(12):1935-44. PubMed ID: 26475093
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
Xi HQ; Zhao P
J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
[TBL] [Abstract][Full Text] [Related]
15. AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier.
Seike M; Kim CH; Zou F; Noro R; Chiba M; Ishikawa A; Κunugi S; Kubota K; Gemma A
Oncol Rep; 2017 Jun; 37(6):3261-3269. PubMed ID: 28440492
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
[TBL] [Abstract][Full Text] [Related]
17. AXL-GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases.
Wu X; Ma W; Zhou Q; Yan H; Lim ZF; Huang M; Deng C; Yu X; Su H; Komo S; Yang H; Zhang X; Wen S; Zhang Z; Ma PC
J Cancer Res Clin Oncol; 2017 Oct; 143(10):1947-1957. PubMed ID: 28551766
[TBL] [Abstract][Full Text] [Related]
18. HER2-positive mucinous adenocarcinomas of the ovary have an expansile invasive pattern associated with a favorable prognosis.
Kim SK; Cho NH
Int J Clin Exp Pathol; 2014; 7(7):4222-30. PubMed ID: 25120802
[TBL] [Abstract][Full Text] [Related]
19. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
20. Independence of the prognostic value of tumor suppressor protein expression in ovarian adenocarcinomas: A multivariate analysis of expression of p53, retinoblastoma, and related proteins.
Tachibana M; Watanabe J; Matsushima Y; Nishida K; Kobayashi Y; Fujimura M; Shiromizu K
Int J Gynecol Cancer; 2003; 13(5):598-606. PubMed ID: 14675342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]